WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'5001 Infant (under 12 months) mortality rate: 432
GDP / capita (US$): 3'8531 Child (under 5 years) mortality rate: 642

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 16'591  16'101  15'621  15'153  14'700  10'531  8'027  5'889 
Births 634  620  607  595  583  472  363  281 
Surviving infants 603  589  576  563  551  429  323  253 
Pop. less than 5 years 2'820  2'750  2'687  2'626  2'569  1'946  1'480  1'148 
Pop. less than 15 years 7'481  7'306  7'140  6'972  6'803  4'890  3'767  2'813 
Female 15-49 years 3'959  3'821  3'685  3'554  3'429  2'429  1'799  1'279 

Number of reported cases

(Click for retrospective incidence data for Zambia)
Diphtheria
ChartChart
  12 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  35  896  30'930  6'748  98'659 
Mumps
ChartChart
  6'213 
Pertussis
ChartChart
  200  21'232 
Polio*
ChartChart
  79  276 
Rubella
ChartChart
  34  94  74  183  134 
Rubella (CRS)
ChartChart
  10 
Tetanus (neonatal)
ChartChart
  130  57 
Tetanus (total)**
ChartChart
  193  57  409 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zambia)
Vaccine year result method % card seen                                                
BCG 2013  95  DHS   80  99  97  95  82  83  99*  97 
DTP1 2013  96  DHS   80  99  97  96  86  86  93 
DTP3 2013  86  DHS   80  99  90  86  79  78  76  71 
DTP4         
IPV1         
HepB_BD         
HepB3 2013  86  DHS   80  99  90  86  79  78 
Hib3 2013  86  DHS   80  99  90  86  79  78 
JapEnc         
MCV1          99  90  85  80  95  85  68 
MCV2          59  47  33 
MenA         
PCV1          99  94  89 
PCV2          99  88  83 
PCV3          98  83  77 
Pol3 2013  78  DHS   80  95  90  78  74  70  79  70 
Rota1          99  90  80 
RotaC          99  82  73 
RCV1         
TT2plus 2013  30  DHS   80  75  75  74  74  71  61 
PAB          77  82 
VAD1          90  99*  99*  59 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zambia)
BCG
ChartChart
  99  97  99  95  92  94  97 
DTP1
ChartChart
  99  97  96  86  86  94  97 
DTP3
ChartChart
  91  90  86  79  78  85  91 
HepB3
ChartChart
  91  90  86  79  78 
HepB_BD
ChartChart
 
Hib3
ChartChart
  91  90  86  79  78 
IPV1
 
MCV1
ChartChart
  93  90  85  80  82  85  90 
MCV2
ChartChart
  58  47  33 
PCV3
ChartChart
  90  81  77 
Pol3
ChartChart
  87  90  78  74  70  85  90 
RCV1
 
RotaC
ChartChart
  90  82  73 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 103  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 65
From 80 to 89% 22
From 50 to 79% 12
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9, 10 years; Yes Demonstration project - From March 2018
IPV 14 weeks; Yes From March 2018
Measles 9, 18 months; Yes
MR 9, 18 months; Yes From April 2017
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes pregnant women and CBAW
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2021  2012-2016  2012-2016  2012-2016  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 103      105  72  72  72 

System performance

Total Nº districts in country number 103  103  74  74  72  72  72 
Nº districts with DTP3 coverage >=80% number 90  79  61  39  50  45  49 
% of districts with DTP3 coverage >=80% From 0 to 100% 87  77  82  53  69  63  68 
Nº districts with measles (MCV1) coverage >=95% number 52  49  25  15  37  25  42 
% of districts with MCV1 coverage >=95% From 0 to 100% 50  48  34  20  51  35  58 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes    Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 19  89  33  69    69   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No  No  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.